NASDAQ : SNOA
Sonoma Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Sonoma Pharmaceuticals, Inc. (SNOA) reported revenue of 21.92M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 21.92M | 19.53M | 14.29M | 12.73M | 13.27M | 12.63M |
| Cost of Revenue | 13.39M | 12.11M | 8.82M | 7.99M | 8.79M | 8.63M |
| Gross Profit | 8.53M | 7.42M | 5.46M | 4.75M | 4.48M | 3.99M |
| Selling, General & Admin | 7.66M | 7.61M | 7.36M | 7.58M | 8.84M | 9.76M |
| Research & Development | 2.27M | 2.27M | 1.81M | 1.87M | 207.00K | 125.00K |
| Operating Expenses | 9.93M | 9.88M | 9.18M | 9.45M | 9.05M | 9.88M |
| Operating Income | -1.41M | -2.46M | -3.71M | -4.70M | -4.57M | -5.89M |
| Interest Expense | -10.00K | |||||
| Currency Exchange Gain (Loss) | 1.30M | 1.45M | 243.00K | -825.00K | -692.00K | -579.00K |
| Other Non Operating Income (Expenses) | -2.40M | -2.40M | 560.00K | 495.00K | 78.00K | 185.00K |
| EBT Excluding Unusual Items | -2.51M | -3.42M | -2.91M | -5.03M | -5.18M | -6.29M |
| Gain (Loss) on Sale of Assets | 150.00K | |||||
| Other Unusual Items | 723.00K | |||||
| Pretax Income | -2.51M | -3.42M | -2.91M | -5.03M | -5.18M | -5.42M |
| Income Tax Expense | -243.00K | -244.00K | 550.00K | -196.00K | -33.00K | -332.00K |
| Earnings From Continuing Operations | -2.26M | -3.17M | -3.46M | -4.83M | -5.15M | -5.09M |
| Net Income | -2.26M | -3.17M | -3.46M | -4.83M | -5.15M | -5.09M |
| Net Income to Common | -2.26M | -3.17M | -3.46M | -4.83M | -5.15M | -5.09M |
| Shares Outstanding (Basic) | 2.24M | 1.68M | 1.24M | 455.00K | 169.70K | 132.65K |
| Shares Outstanding (Diluted) | 2.24M | 1.68M | 1.24M | 455.00K | 169.70K | 132.65K |
| EPS (Basic) | -1.01 | -1.89 | -2.79 | -10.63 | -30.35 | -38.34 |
| EPS (Diluted) | -1.01 | -1.89 | -2.79 | -10.63 | -30.35 | -38.34 |
| Free Cash Flow | -2.65M | -4.12M | -168.00K | -2.40M | -6.42M | -4.38M |
| Free Cash Flow Per Share | -1.19 | -2.45 | -0.14 | -5.28 | -37.84 | -33.06 |
| Gross Margin | 38.91% | 37.97% | 38.25% | 37.26% | 33.73% | 31.62% |
| Operating Margin | -6.41% | -12.60% | -25.97% | -36.91% | -34.43% | -46.62% |
| Profit Margin | -10.33% | -16.26% | -24.20% | -37.97% | -38.81% | -40.28% |
| Free Cash Flow Margin | -12.11% | -21.12% | -1.18% | -18.85% | -48.38% | -34.72% |
| EBITDA | -1.27M | -2.32M | -3.57M | -4.53M | -4.45M | -5.70M |
| EBITDA Margin | -5.80% | -11.89% | -25.00% | -35.53% | -33.49% | -45.15% |
| D&A For EBITDA | 135.00K | 139.00K | 138.00K | 176.00K | 125.00K | 186.00K |
| EBIT | -1.41M | -2.46M | -3.71M | -4.70M | -4.57M | -5.89M |
| EBIT Margin | -6.41% | -12.60% | -25.97% | -36.91% | -34.43% | -46.62% |
| Advertising Expenses | 91.00K | 190.00K | 156.00K | 156.00K | 86.00K |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.34M | 2.40M | 5.37M | 3.13M | 3.82M | 7.40M |
| Cash & Short-Term Investments | 5.34M | 2.40M | 5.37M | 3.13M | 3.82M | 7.40M |
| Accounts Receivable | 3.18M | 2.53M | 2.23M | 2.90M | 2.57M | 2.41M |
| Other Receivables | 87.00K | 212.00K | 262.00K | 240.00K | 218.00K | |
| Receivables | 3.18M | 2.61M | 2.44M | 3.16M | 2.81M | 2.62M |
| Inventory | 3.79M | 3.65M | 2.92M | 2.72M | 2.86M | 2.66M |
| Prepaid Expenses | 3.96M | 3.44M | 1.92M | 3.54M | 4.31M | 3.75M |
| Total Current Assets | 16.27M | 12.10M | 12.65M | 12.55M | 13.80M | 16.43M |
| Property, Plant & Equipment | 868.00K | 912.00K | 309.00K | 651.00K | 906.00K | 879.00K |
| Long-Term Deferred Tax Assets | 905.00K | 884.00K | 589.00K | 1.15M | 949.00K | 829.00K |
| Other Long-Term Assets | 66.00K | 64.00K | 147.00K | 396.00K | 578.00K | 707.00K |
| Total Assets | 18.11M | 13.96M | 13.69M | 14.74M | 16.23M | 18.84M |
| Accounts Payable | 2.19M | 1.92M | 953.00K | 607.00K | 841.00K | 1.64M |
| Accrued Expenses | 2.67M | 1.72M | 1.74M | 1.42M | 1.46M | 1.06M |
| Short-Term Debt | 140.00K | 222.00K | 220.00K | 323.00K | 431.00K | 688.00K |
| Current Portion of Long-Term Debt | 120.00K | |||||
| Current Portion of Leases | 160.00K | 151.00K | 58.00K | 198.00K | 256.00K | 250.00K |
| Current Unearned Revenue | 282.00K | 284.00K | 641.00K | 478.00K | 160.00K | 1.28M |
| Other Current Liabilities | 533.00K | 487.00K | 694.00K | 566.00K | 784.00K | |
| Total Current Liabilities | 5.45M | 4.83M | 4.10M | 3.72M | 3.72M | 5.82M |
| Long-Term Leases | 439.00K | 469.00K | 27.00K | 87.00K | 162.00K | 309.00K |
| Long-Term Unearned Revenue | 17.00K | 87.00K | 140.00K | 182.00K | ||
| Other Long-Term Liabilities | 5.63M | 5.56M | 5.14M | 4.71M | 4.24M | 3.84M |
| Total Liabilities | 11.51M | 10.87M | 9.28M | 8.60M | 8.25M | 10.15M |
| Common Stock | 5.00K | 2.00K | ||||
| Additional Paid-In Capital | 210.91M | 207.32M | 206.59M | 203.21M | 200.90M | 197.37M |
| Retained Earnings | -201.31M | -200.98M | -197.81M | -194.35M | -189.51M | -184.36M |
| Comprehensive Income & Other | -3.01M | -3.24M | -4.38M | -2.72M | -3.42M | -4.31M |
| Shareholders' Equity | 6.59M | 3.10M | 4.41M | 6.14M | 7.98M | 8.70M |
| Total Liabilities & Equity | 18.11M | 13.96M | 13.69M | 14.74M | 16.23M | 18.84M |
| Total Debt | 739.00K | 842.00K | 305.00K | 608.00K | 849.00K | 1.37M |
| Net Cash (Debt) | 4.60M | 1.56M | 5.07M | 2.52M | 2.97M | 6.03M |
| Net Cash Per Share | 2.06 | 0.92 | 4.08 | 5.54 | 17.51 | 45.45 |
| Filing Date Shares Outstanding | 4.79M | 4.79M | 1.64M | 938.68K | 247.08K | 155.05K |
| Total Common Shares Outstanding | 4.79M | 1.80M | 1.63M | 780.37K | 246.68K | 155.05K |
| Working Capital | 10.82M | 7.27M | 8.55M | 8.83M | 10.08M | 10.61M |
| Book Value Per Share | 1.38 | 1.72 | 2.70 | 7.86 | 32.34 | 56.09 |
| Tangible Book Value | 6.59M | 3.10M | 4.41M | 6.14M | 7.98M | 8.70M |
| Tangible Book Value Per Share | 1.38 | 1.72 | 2.70 | 7.86 | 32.34 | 56.09 |
| Machinery | 2.23M | 1.81M | 2.14M | 1.95M | 1.53M | |
| Leasehold Improvements | 556.00K | 491.00K | 605.00K | 554.00K | 503.00K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -2.26M | -3.17M | -3.46M | -4.83M | -5.15M | -5.09M |
| Depreciation & Amortization | 135.00K | 139.00K | 138.00K | 176.00K | 125.00K | 186.00K |
| Loss (Gain) From Sale of Assets | -1.00K | |||||
| Stock-Based Compensation | 256.00K | 255.00K | 224.00K | 516.00K | 669.00K | 382.00K |
| Provision & Write-off of Bad Debts | -125.00K | |||||
| Other Operating Activities | -351.00K | -746.00K | 531.00K | 52.00K | 136.00K | -2.74M |
| Change in Accounts Receivable | -556.00K | -122.00K | 434.00K | -230.00K | -4.00K | 1.97M |
| Change in Inventory | 106.00K | -465.00K | -388.00K | 184.00K | -100.00K | |
| Change in Accounts Payable | 61.00K | 871.00K | 416.00K | -278.00K | -864.00K | -157.00K |
| Change in Unearned Revenue | -486.00K | -452.00K | 181.00K | 355.00K | -1.30M | 900.00K |
| Change in Other Net Operating Assets | 532.00K | -238.00K | 1.83M | 1.66M | 234.00K | 517.00K |
| Operating Cash Flow | -2.57M | -3.93M | -88.00K | -2.40M | -6.15M | -4.25M |
| Capital Expenditures | -88.00K | -192.00K | -80.00K | -2.00K | -269.00K | -137.00K |
| Other Investing Activities | 11.00K | 38.00K | ||||
| Investing Cash Flow | -88.00K | -192.00K | -80.00K | -2.00K | -258.00K | -99.00K |
| Short-Term Debt Issued | 277.00K | 274.00K | 373.00K | 515.00K | 123.00K | |
| Total Debt Issued | 277.00K | 277.00K | 274.00K | 373.00K | 515.00K | 123.00K |
| Short-Term Debt Repaid | -271.00K | -404.00K | -481.00K | -774.00K | -30.00K | |
| Long-Term Debt Repaid | -120.00K | -467.00K | ||||
| Total Debt Repaid | -272.00K | -271.00K | -404.00K | -481.00K | -894.00K | -497.00K |
| Net Debt Issued (Repaid) | 5.00K | 6.00K | -130.00K | -108.00K | -379.00K | -374.00K |
| Issuance of Common Stock | 3.98M | 471.00K | 3.16M | 1.78M | 2.87M | 7.77M |
| Repurchase of Common Stock | -1.00K | |||||
| Financing Cash Flow | 3.99M | 477.00K | 3.03M | 1.68M | 2.49M | 7.40M |
| Foreign Exchange Rate Adjustments | 399.00K | 673.00K | -616.00K | 32.00K | 345.00K | 127.00K |
| Net Cash Flow | 1.73M | -2.98M | 2.25M | -692.00K | -3.58M | 3.18M |
| Free Cash Flow | -2.65M | -4.12M | -168.00K | -2.40M | -6.42M | -4.38M |
| Free Cash Flow Margin | -12.11% | -21.12% | -1.18% | -18.85% | -48.38% | -34.72% |
| Free Cash Flow Per Share | -1.19 | -2.45 | -0.14 | -5.28 | -37.84 | -33.06 |
| Levered Free Cash Flow | -1.47M | -3.12M | 729.25K | -1.52M | -5.01M | -2.01M |
| Unlevered Free Cash Flow | -1.47M | -3.12M | 729.25K | -1.52M | -5.01M | -2.00M |
| Cash Interest Paid | 6.00K | 6.00K | 11.00K | 22.00K | 17.00K | 24.00K |
| Cash Income Tax Paid | 767.00K | |||||
| Change in Working Capital | -343.00K | -406.00K | 2.48M | 1.69M | -1.93M | 3.13M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.27M | 3.69M | 3.54M | 2.60M | 4.54M | 12.43M |
| Enterprise Value | 668.27K | 1.78M | -1.58M | 574.51K | 2.39M | 5.11M |
| Last Close Price | 1.10 | 2.13 | 2.19 | 3.33 | 19.53 | 80.20 |
| Forward PE | 11.93 | 11.93 | 11.93 | 11.93 | 11.93 | |
| PS Ratio | 0.24 | 0.19 | 0.25 | 0.20 | 0.34 | 0.98 |
| PB Ratio | 0.80 | 1.19 | 0.80 | 0.42 | 0.57 | 1.43 |
| P/TBV Ratio | 0.80 | 1.19 | 0.80 | 0.42 | 0.57 | 1.43 |
| PEG Ratio | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | |
| EV/Sales Ratio | 0.03 | 0.09 | 0.04 | 0.18 | 0.41 | |
| Debt / Equity Ratio | 0.11 | 0.27 | 0.07 | 0.10 | 0.11 | 0.16 |
| Net Debt / Equity Ratio | -0.70 | -0.50 | -1.15 | -0.41 | -0.37 | -0.69 |
| Net Debt / EBITDA Ratio | 3.62 | 0.67 | 1.42 | 0.56 | 0.67 | 1.06 |
| Net Debt / FCF Ratio | 1.73 | 0.38 | 30.17 | 1.05 | 0.46 | 1.38 |
| Asset Turnover | 1.34 | 1.41 | 1.00 | 0.82 | 0.76 | 0.75 |
| Inventory Turnover | 3.53 | 3.69 | 3.13 | 2.87 | 3.19 | 3.33 |
| Quick Ratio | 1.56 | 1.04 | 1.91 | 1.69 | 1.78 | 1.72 |
| Current Ratio | 2.99 | 2.50 | 3.09 | 3.37 | 3.71 | 2.82 |
| Return on Equity (ROE) | -42.52% | -84.60% | -65.55% | -68.51% | -61.79% | -72.35% |
| Return on Assets (ROA) | -5.37% | -11.12% | -16.31% | -18.97% | -16.29% | -21.75% |
| Return on Capital Employed (ROCE) | -11.10% | -27.00% | -38.70% | -42.70% | -36.50% | -45.20% |
| Earnings Yield | -92.08% | -86.13% | -97.70% | -186.28% | -113.48% | -40.92% |
| FCF Yield | -50.41% | -111.90% | -4.75% | -92.47% | -141.46% | -35.28% |
| Buyback Yield / Dilution | -55.39% | -35.70% | -172.75% | -168.12% | -27.93% | -32.92% |